Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Shadlen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|July 11, 2022
Accelerating pooled licensing of medicines to enhance global production and equitable accessKenneth C Shadlen
Politics & Society|September 15, 2011
The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in BrazilKenneth C Shadlen
Plos One|April 3, 2018
Indian pharmaceutical patent prosecution: The changing role of Section 3(d)Bhaven N Sampat, Kenneth C Shadlen
Health Affairs Scholar|May 17, 2024
Contrasting academic approaches to COVID-19 vaccine production and distribution: What can the Oxford and Texas experiences teach us about pandemic response?Jorge L Contreras, Kenneth C Shadlen
Nature Reviews. Drug Discovery|July 18, 2015
Patent watch: Drug patenting in India: looking back and looking forwardBhaven N Sampat, Kenneth C Shadlen
Health Affairs (Project Hope)|February 4, 2021
The COVID-19 Innovation SystemBhaven N Sampat, Kenneth C Shadlen
European Journal of Public Health|March 20, 2026
Aligning health, industry, and innovation through public procurementElize Massard da Fonseca, Kenneth C Shadlen
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|April 27, 2017
Promoting and regulating generic medicines: Brazil in comparative perspectiveElize Massard da Fonseca, Kenneth C Shadlen
Health Affairs Scholar|February 27, 2026
TRIPS, pharmaceutical patents, and generic competition in IndiaMargaret K Kyle, Bhaven N Sampat, Kenneth C Shadlen
Science (New York, N.Y.)|July 7, 2012
Intellectual property. Challenges to India's pharmaceutical patent lawsBhaven N Sampat, Kenneth C Shadlen, Tahir M Amin
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|July 11, 2022
Accelerating pooled licensing of medicines to enhance global production and equitable accessKenneth C Shadlen
Politics & Society|September 15, 2011
The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in BrazilKenneth C Shadlen
Plos One|April 3, 2018
Indian pharmaceutical patent prosecution: The changing role of Section 3(d)Bhaven N Sampat, Kenneth C Shadlen
Health Affairs Scholar|May 17, 2024
Contrasting academic approaches to COVID-19 vaccine production and distribution: What can the Oxford and Texas experiences teach us about pandemic response?Jorge L Contreras, Kenneth C Shadlen
Nature Reviews. Drug Discovery|July 18, 2015
Patent watch: Drug patenting in India: looking back and looking forwardBhaven N Sampat, Kenneth C Shadlen
Health Affairs (Project Hope)|February 4, 2021
The COVID-19 Innovation SystemBhaven N Sampat, Kenneth C Shadlen
European Journal of Public Health|March 20, 2026
Aligning health, industry, and innovation through public procurementElize Massard da Fonseca, Kenneth C Shadlen
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|April 27, 2017
Promoting and regulating generic medicines: Brazil in comparative perspectiveElize Massard da Fonseca, Kenneth C Shadlen
Health Affairs Scholar|February 27, 2026
TRIPS, pharmaceutical patents, and generic competition in IndiaMargaret K Kyle, Bhaven N Sampat, Kenneth C Shadlen
Science (New York, N.Y.)|July 7, 2012
Intellectual property. Challenges to India's pharmaceutical patent lawsBhaven N Sampat, Kenneth C Shadlen, Tahir M Amin
Pageof 2